Mayo Clinic Laboratory and pathology research roundup: November 15 - Insights
This week's research roundup features: Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors
Mayo Clinic Laboratory and pathology research roundup: September 20 - Insights
This week's research roundup features: Into the future: a pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer
Mayo Clinic Laboratory and Pathology Research Roundup: July 31 - Insights
This week’s Research Roundup highlights urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 11 - Insights
This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 9 - Insights
This week’s Research Roundup highlights a subset of well-differentiated hepatocellular carcinomas that are arginase-1 negative.
Mayo Clinic Laboratory and Pathology Research Roundup: July 10 - Insights
This week’s Research Roundup highlights the association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery.
Mayo Clinic Laboratory and Pathology Research Roundup: June 5 - Insights
This week’s Research Roundup highlights oncologic outcomes for patients with residual cancer at cystectomy following neoadjuvant chemotherapy.
Mayo Clinic Laboratory and Pathology Research Roundup: June 19 - Insights
This week’s Research Roundup highlights the single-nephron glomerular filtration rate in healthy adults.
Researchers at Mayo Clinic have identified a possible cause for a rare infection in heart and lung transplant recipients: the donor.
Mayo Clinic Laboratory and Pathology Research Roundup: May 15 - Insights
This week’s Research Roundup highlights how the androgen receptor variant AR-V9 is co-expressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance.